CoChat

Interactions Between Cholinergic and Fibroblast Growth Factor Receptors in Brain Trophism and Plasticity

Open access
Liberto, Valentina, Mudo, Giuseppa, Fuxe, Kjell, Belluardo, Natale · 2014 · Current Protein & Peptide Science

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

Acetylcholine, acting on both nicotinic receptors (nAChRs) and muscarinic receptors (mAChRs), plays a role in the regulation of synaptic plasticity, being involved in the regulation of cellular processes and cognitive functions, such as learning, memory and attention. Recently, G protein coupled receptors (GPCRs), including mAChRs, have been reported to transactivate tyrosine-kinase receptors (RTK), such as epidermal growth factor receptor (EGFR), and initiate their intracellular signaling. In this minireview we have first analysed the RTK transactivation mechanisms, involving cholinergic receptors, and thereafter the interplay between AChR and neurotrophic factor systems built up by FGF2 and fibroblast growth factor receptor 1 (FGFR1). Although mAChR and FGFR1 activate common signaling pathways, playing similar roles in the regulation of central nervous system (CNS) plasticity and trophism, this analysis revealed that at the present there are no data reporting an involvement of cholinergic receptors in the FGFR1 transactivation. However, here we reported preliminary results on FGFR1 transactivation by mAChRs, suggesting a possible interaction between mAChR and neurotrophic factor receptors, with potential relevance for cognitive functions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2174/1389203715666140901112245

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Research works printed but not linked: 197

  1. [1][1] Bentley, P.; Driver, J.; Dolan, R.J. Cholinergic modulation of cognition: insights from human pharmacological functional neuroimaging. Prog. Neurobiol., 2011, 94(4), 360-388. -
  2. [3][3] Sarter, M.; Bruno, J.P. Cognitive functions of cortical acetylcholine: toward a unifying hypothesis. Brain Res. Brain Res. Rev., 1997, 23(1-2), 28-46. -
  3. [2][2] Blokland, A. Acetylcholine: a neurotransmitter for learning and memory? Brain Res. Brain Res. Rev., 1995, 21(3), 285-300. -
  4. [7][7] Hasselmo, M.E.; Anderson, B.P.; Bower, J.M. Cholinergic modulation of cortical associative memory function. J. Neurophysiol., 1992, 67(5), 1230-1246. - [6] Parikh, V.; Kozak, R.; Martinez, V.; Sarter, M. Prefrontal acetylcholine release controls cue detection on multiple timescales. Neuron, 2007, 56(1), 141-154. -
  5. [10][10] Klinkenberg, I.; Sambeth, A.; Blokland, A. Acetylcholine and attention. Behav. Brain Res., 2011, 221(2), 430-442. -
  6. [13][13] Wess, J. Molecular biology of muscarinic acetylcholine receptors. Crit Rev. Neurobiol., 1996, 10(1), 69-99. -
  7. [15][15] Nathanson, N.M. A multiplicity of muscarinic mechanisms: enough signaling pathways to take your breath away. Proc. Natl. Acad. Sci. U. S. A, 2000, 97(12), 6245-6247. -
  8. [19][19] Marinissen, M.J.; Gutkind, J.S. G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol. Sci., 2001, 22(7), 368-376. -
  9. [21][21] Hohmann, C.F.; Potter, E.D.; Levey, A.I. Development of muscarinic receptor subtypes in the forebrain of the mouse. J. Comp Neurol., 1995, 358(1), 88-101. -
  10. [22][22] Levey, A.I. Immunological localization of m1-m5 muscarinic acetylcholine receptors in peripheral tissues and brain. Life Sci., 1993, 52(5-6), 441-448. -
  11. [28][28] Weiner, D.M.; Levey, A.I.; Brann, M.R. Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. Proc. Natl. Acad. Sci. U. S. A, 1990, 87(18), 7050-7054. -
  12. [31][31] Brown, D.A. Muscarinic acetylcholine receptors (mAChRs) in the nervous system: some functions and mechanisms. J. Mol. Neurosci., 2010, 41(3), 340-346. -
  13. [33][33] Seeger, T.; Fedorova, I.; Zheng, F.; Miyakawa, T.; Koustova, E.; Gomeza, J.; Basile, A.S.; Alzheimer, C.; Wess, J. M2 muscarinic acetylcholine receptor knock-out mice show deficits in behavioral flexibility, working memory, and hippocampal plasticity. J. Neurosci., 2004, 24(45), 10117-10127. -
  14. [32][32] Leung, L.S.; Shen, B.; Rajakumar, N.; Ma, J. Cholinergic activity enhances hippocampal long-term potentiation in CA1 during walking in rats. J. Neurosci., 2003, 23(28), 9297-9304. -
  15. [35][35] Shinoe, T.; Matsui, M.; Taketo, M.M.; Manabe, T. Modulation of synaptic plasticity by physiological activation of M1 muscarinic acetylcholine receptors in the mouse hippocampus. J. Neurosci., 2005, 25(48), 11194-11200. -
  16. [36][36] Doralp, S.; Leung, L.S. Cholinergic modulation of hippocampal CA1 basal-dendritic long-term potentiation. Neurobiol. Learn. Mem., 2008, 90(2), 382-388. -
  17. [40][40] Dickinson, B.A.; Jo, J.; Seok, H.; Son, G.H.; Whitcomb, D.J.; Davies, C.H.; Sheng, M.; Collingridge, G.L.; Cho, K. A novel mechanism of hippocampal LTD involving muscarinic receptortriggered interactions between AMPARs, GRIP and liprin-alpha. Mol. Brain, 2009, 2, 18. -
  18. [41][41] Caruana, D.A.; Warburton, E.C.; Bashir, Z.I. Induction of activitydependent LTD requires muscarinic receptor activation in medial prefrontal cortex. J. Neurosci., 2011, 31(50), 18464-18478. -
  19. [43][43] Lane, R.M.; Potkin, S.G.; Enz, A. Targeting acetylcholinesterase and butyrylcholinesterase in dementia. Int. J. Neuropsychopharmacol., 2006, 9(1), 101-124. -
  20. [49][49] Caccamo, A.; Fisher, A.; LaFerla, F.M. M1 agonists as a potential disease-modifying therapy for Alzheimer's disease. Curr. Alzheimer Res., 2009, 6(2), 112-117. -
  21. [51][51] Wallace, T.L.; Porter, R.H. Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease. Biochem. Pharmacol., 2011, 82(8), 891-903. -
  22. [57][57] Lanzafame, A.A.; Christopoulos, A.; Mitchelson, F. Cellular signaling mechanisms for muscarinic acetylcholine receptors. Receptors. Channels, 2003, 9(4), 241-260. -
  23. [58][58] Leloup, C.; Michaelson, D.M.; Fisher, A.; Hartmann, T.; Beyreuther, K.; Stein, R. M1 muscarinic receptors block caspase - activation by phosphoinositide 3-kinase- and MAPK/ERKindependent pathways. Cell Death. Differ., 2000, 7(9), 825-833. -
  24. [63][63] Li, B.S.; Ma, W.; Zhang, L.; Barker, J.L.; Stenger, D.A.; Pant, H.C. Activation of phosphatidylinositol-3 kinase (PI-3K) and extracellular regulated kinases (Erk1/2) is involved in muscarinic receptor-mediated DNA synthesis in neural progenitor cells. J. Neurosci., 2001, 21(5), 1569-1579. -
  25. [64][64] Almasieh, M.; Zhou, Y.; Kelly, M.E.; Casanova, C.; Di, P.A. Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptors. Cell Death. Dis., 2010, 1, e27. -
  26. [66][66] Marte, B.M.; Downward, J. PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem. Sci., 1997, 22(9), 355-358. -
  27. [65][65] Zhu, X.; Zhou, W.; Cui, Y.; Zhu, L.; Li, J.; Feng, X.; Shao, B.; Qi, H.; Zheng, J.; Wang, H.; Chen, H. Pilocarpine protects cobalt chloride-induced apoptosis of RGC-5 cells: involvement of muscarinic receptors and HIF-1 alpha pathway. Cell Mol. Neurobiol., 2010, 30(3), 427-435. -
  28. [67][67] Dudek, H.; Datta, S.R.; Franke, T.F.; Birnbaum, M.J.; Yao, R.; Cooper, G.M.; Segal, R.A.; Kaplan, D.R.; Greenberg, M.E. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science, 1997, 275(5300), 661-665. -
  29. [69][69] Budd, D.C.; McDonald, J.; Emsley, N.; Cain, K.; Tobin, A.B. The C-terminal tail of the M3-muscarinic receptor possesses antiapoptotic properties. J. Biol. Chem., 2003, 278(21), 19565-19573. -
  30. [68][68] Kulik, G.; Klippel, A.; Weber, M.J. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol. Cell Biol., 1997, 17(3), 1595-1606. -
  31. [70][70] Navakkode, S.; Korte, M. Cooperation between cholinergic and glutamatergic receptors are essential to induce BDNF-dependent long-lasting memory storage. Hippocampus, 2012, 22(2), 335-346. -
  32. [72][72] Lindholm, D.; da Penha, B.M.; Cooper, J.; Thoenen, H.; Castren, E. Brain-derived neurotrophic factor and neurotrophin-4 increase neurotrophin-3 expression in the rat hippocampus. Int. J. Dev. Neurosci., 1994, 12(8), 745-751. -
  33. [71][71] French, S.J.; Humby, T.; Horner, C.H.; Sofroniew, M.V.; Rattray, M. Hippocampal neurotrophin and trk receptor mRNA levels are altered by local administration of nicotine, carbachol and pilocarpine. Brain Res. Mol. Brain Res., 1999, 67(1), 124-136. -
  34. [73][73] Mudo, G.; Jiang, X.H.; Timmusk, T.; Bindoni, M.; Belluardo, N. Change in neurotrophins and their receptor mRNAs in the rat forebrain after status epilepticus induced by pilocarpine. Epilepsia, 1996, 37(2), 198-207. -
  35. [75][75] Whiteaker, P.; Davies, A.R.; Marks, M.J.; Blagbrough, I.S.; Potter, B.V.; Wolstenholme, A.J.; Collins, A.C.; Wonnacott, S. An autoradiographic study of the distribution of binding sites for the novel alpha7-selective nicotinicradioligand[3H]methyllycaconitine in the mouse brain. Eur. J. Neurosci., 1999, 11(8), 2689-2696. -
  36. [74][74] Wu, J.; Lukas, R.J. Naturally-expressed nicotinic acetylcholine receptor subtypes. Biochem. Pharmacol., 2011, 82(8), 800-807. -
  37. [76][76] Wonnacott, S. Presynaptic nicotinic ACh receptors. Trends Neurosci., 1997, 20 (2), 92-98. -
  38. [77][77] Fujii, S.; Ji, Z.; Morita, N.; Sumikawa, K. Acute and chronic nicotine exposure differentially facilitate the induction of LTP. Brain Res., 1999, 846(1), 137-143. -
  39. [80][80] Sharma, G.; Vijayaraghavan, S. Modulation of presynaptic store calcium induces release of glutamate and postsynaptic firing. Neuron, 2003, 38(6), 929-939. -
  40. [85][85] Shaw, S.; Bencherif, M.; Marrero, M.B. Janus kinase 2, an early target of alpha 7 nicotinic acetylcholine receptor-mediated neuroprotection against Abeta-(1-42) amyloid. J. Biol. Chem., 2002, 277(47), 44920-44924. -
  41. [87][87] Liu, Y.; Hu, J.; Wu, J.; Zhu, C.; Hui, Y.; Han, Y.; Huang, Z.; Ellsworth, K.; Fan, W. alpha7 nicotinic acetylcholine receptormediated neuroprotection against dopaminergic neuron loss in an MPTP mouse model via inhibition of astrocyte activation. J. Neuroinflammation., 2012, 9, 98. -
  42. [86][86] Kihara, T.; Shimohama, S.; Sawada, H.; Honda, K.; Nakamizo, T.; Shibasaki, H.; Kume, T.; Akaike, A. alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A betaamyloid-induced neurotoxicity. J. Biol. Chem., 2001, 276(17), 13541-13546. -
  43. [88][88] Hejmadi, M.V.; Dajas-Bailador, F.; Barns, S.M.; Jones, B.; Wonnacott, S. Neuroprotection by nicotine against hypoxiainduced apoptosis in cortical cultures involves activation of multiple nicotinic acetylcholine receptor subtypes. Mol. Cell Neurosci., 2003, 24(3), 779-786. - [06] Orr-Urtreger, A.; Broide, R.S.; Kasten, M.R.; Dang, H.; Dani, J.A.; Beaudet, A.L.; Patrick, J.W. Mice homozygous for the L250T mutation in the alpha7 nicotinic acetylcholine receptor show increased neuronal apoptosis and die within 1 day of birth. J. Neurochem., 2000, 74(5), 2154-2166. -
  44. [89][89] Ueda, M.; Iida, Y.; Kitamura, Y.; Kawashima, H.; Ogawa, M.; Magata, Y.; Saji, H. 5-Iodo-A-85380, a specific ligand for alpha 4 beta 2 nicotinic acetylcholine receptors, prevents glutamate neurotoxicity in rat cortical cultured neurons. Brain Res., 2008, 1199, 46-52. -
  45. [91][91] Nanri, M.; Yamamoto, J.; Miyake, H.; Watanabe, H. Protective effect of GTS-21, a novel nicotinic receptor agonist, on delayed neuronal death induced by ischemia in gerbils. Jpn. J. Pharmacol., 1998, 76(1), 23-29. -
  46. [93][93] Zeidler, R.; Albermann, K.; Lang, S. Nicotine and apoptosis. Apoptosis., 2007, 12(11), 1927-1943. -
  47. [92][92] Martin, L.F.; Kem, W.R.; Freedman, R. Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia. Psychopharmacology (Berl), 2004, 174(1), 54-64. -
  48. [94][94] Mai, H.; May, W.S.; Gao, F.; Jin, Z.; Deng, X. A functional role for nicotine in Bcl2 phosphorylation and suppression of apoptosis. J. Biol. Chem., 2003, 278(3), 1886-1891. -
  49. [96][96] Mazzucchelli, C.; Brambilla, R. Ras-related and MAPK signalling in neuronal plasticity and memory formation. Cell Mol. Life Sci., 2000, 57(4), 604-611. -
  50. [95][95] Finkbeiner, S. CREB couples neurotrophin signals to survival messages. Neuron, 2000, 25(1), 11-14. -
  51. [97][97] Zhu, Y.; Culmsee, C.; Klumpp, S.; Krieglstein, J. Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways. Neuroscience, 2004, 123(4), 897906. - [66] Kita, Y.; Ago, Y.; Takano, E.; Fukada, A.; Takuma, K.; Matsuda, T. Galantamine increases hippocampal insulin-like growth factor 2 expression via alpha7 nicotinic acetylcholine receptors in mice. Psychopharmacology (Berl), 2013, 225(3), 543-551. -
  52. [98][98] Belluardo, N.; Mudo, G.; Blum, M.; Itoh, N.; Agnati, L.; Fuxe, K. Nicotine-induced FGF-2 mRNA in rat brain is preserved during aging. Neurobiol. Aging, 2004, 25(10), 1333-1342. -
  53. [100][100] Frinchi, M.; Di, L., V; Olivieri, M.; Fuxe, K.; Belluardo, N.; Mudo, G. FGF-2/FGFR1 neurotrophic system expression level and its basal activation do not account for the age-dependent decline of precursor cell proliferation in the subventricular zone of rat brain. Brain Res., 2010, 1358, 39-45. -
  54. [101][101] Mudo, G.; Belluardo, N.; Mauro, A.; Fuxe, K. Acute intermittent nicotine treatment induces fibroblast growth factor-2 in the subventricular zone of the adult rat brain and enhances neuronal precursor cell proliferation. Neuroscience, 2007, 145(2), 470-483. -
  55. [103][103] Takarada, T.; Nakamichi, N.; Kitajima, S.; Fukumori, R.; Nakazato, R.; Le, N.Q.; Kim, Y.H.; Fujikawa, K.; Kou, M.; Yoneda, Y. Promoted neuronal differentiation after activation of alpha4/beta2 nicotinic acetylcholine receptors in undifferentiated neural progenitors. PLoS One, 2012, 7(10), e46177. -
  56. [102][102] Mudo, G.; Bonomo, A.; Di, L., V; Frinchi, M.; Fuxe, K.; Belluardo, N. The FGF-2/FGFRs neurotrophic system promotes neurogenesis in the adult brain. J. Neural Transm., 2009, 116(8), 995-1005. -
  57. [104][104] Ishizuka, T.; Goshima, H.; Ozawa, A.; Watanabe, Y. Effect of nicotine on the proliferation and differentiation of mouse induced pluripotent stem cells. Curr. Med. Chem., 2012, 19(30), 5164-5169. -
  58. [106][106] Harrist, A.; Beech, R.D.; King, S.L.; Zanardi, A.; Cleary, M.A.; Caldarone, B.J.; Eisch, A.; Zoli, M.; Picciotto, M.R. Alteration of hippocampal cell proliferation in mice lacking the beta 2 subunit of the neuronal nicotinic acetylcholine receptor. Synapse, 2004, 54(4), 200-206. -
  59. [105][105] Dasgupta, P.; Chellappan, S.P. Nicotine-mediated cell proliferation and angiogenesis: new twists to an old story. Cell Cycle, 2006, 5(20), 2324-2328. -
  60. [107][107] Sharma, G.; Vijayaraghavan, S. Nicotinic receptor signaling in nonexcitable cells. J. Neurobiol., 2002, 53(4), 524-534. -
  61. [109][109] Shah, B.H.; Catt, K.J. GPCR-mediated transactivation of RTKs in the CNS: mechanisms and consequences. Trends Neurosci., 2004, 27(1), 48-53. -
  62. [108][108] Lowes, V.L.; Ip, N.Y.; Wong, Y.H. Integration of signals from receptor tyrosine kinases and g protein-coupled receptors. Neurosignals., 2002, 11(1), 5-19. -
  63. [110][110] Liebmann, C. EGF receptor activation by GPCRs: an universal pathway reveals different versions. Mol. Cell Endocrinol., 2011, 331(2), 222-231. -
  64. [111][111] Waters, C.; Pyne, S.; Pyne, N.J. The role of G-protein coupled receptors and associated proteins in receptor tyrosine kinase signal transduction. Semin. Cell Dev. Biol., 2004, 15(3), 309-323. -
  65. [112][112] Delcourt, N.; Bockaert, J.; Marin, P. GPCR-jacking: from a new route in RTK signalling to a new concept in GPCR activation. Trends Pharmacol. Sci., 2007, 28(12), 602-607. -
  66. [114][114] Luttrell, L.M.; van, B.T.; Hawes, B.E.; Koch, W.J.; Touhara, K.; Lefkowitz, R.J. G beta gamma subunits mediate mitogen-activated protein kinase activation by the tyrosine kinase insulin-like growth factor 1 receptor. J. Biol. Chem., 1995, 270(28), 16495-16498. -
  67. [113][113] Little, P.J.; Burch, M.L.; Al-aryahi, S.; Zheng, W. The paradigm of G protein receptor transactivation: a mechanistic definition and novel example. Scientific World J., 2011, 11, 709-714. -
  68. [115][115] Povsic, T.J.; Kohout, T.A.; Lefkowitz, R.J. Beta-arrestin1 mediates insulin-like growth factor 1 (IGF-1) activation of phosphatidylinositol 3-kinase (PI3K) and anti-apoptosis. J. Biol. Chem., 2003, 278(51), 51334-51339. -
  69. [116][116] Natarajan, K.; Berk, B.C. Crosstalk coregulation mechanisms of G protein-coupled receptors and receptor tyrosine kinases. Methods Mol. Biol., 2006, 332, 51-77. -
  70. [118][118] Gilmore, A.P.; Valentijn, A.J.; Wang, P.; Ranger, A.M.; Bundred, N.; O'Hare, M.J.; Wakeling, A.; Korsmeyer, S.J.; Streuli, C.H. Activation of BAD by therapeutic inhibition of epidermal growth factor receptor and transactivation by insulin-like growth factor receptor. J. Biol. Chem., 2002, 277(31), 27643-27650. -
  71. [117][117] Roudabush, F.L.; Pierce, K.L.; Maudsley, S.; Khan, K.D.; Luttrell, L.M. Transactivation of the EGF receptor mediates IGF-1stimulated shc phosphorylation and ERK1/2 activation in COS-7 cells. J. Biol. Chem., 2000, 275(29), 22583-22589. -
  72. [119][119] Daub, H.; Wallasch, C.; Lankenau, A.; Herrlich, A.; Ullrich, A. Signal characteristics of G protein-transactivated EGF receptor. EMBO J., 1997, 16(23), 7032-7044. -
  73. [120][120] Daub, H.; Weiss, F.U.; Wallasch, C.; Ullrich, A. Role of -tnlii rtii lio I siein coupled receptors. Nature, 1996, 379(6565), 557-560. -
  74. [121][121] Ohtsu, H.; Dempsey, P.J.; Eguchi, S. ADAMs as mediators of EGF receptor transactivation by G protein-coupled receptors. Am. J. Physiol Cell Physiol, 2006, 291(1), C1-10. -
  75. [123][123] Borroto-Escuela, D.O.; Romero-Fernandez, W.; Mudo, G.; PerezAlea, M.; Ciruela, F.; Tarakanov, A.O.; Narvaez, M.; Di, L., V; Agnati, L.F.; Belluardo, N.; Fuxe, K. Fibroblast growth factor receptor 1- 5-hydroxytryptamine 1A heteroreceptor complexes and their enhancement of hippocampal plasticity. Biol. Psychiatry, 2012, 71(1), 84-91. -
  76. [122][122] Prenzel, N.; Zwick, E.; Daub, H.; Leserer, M.; Abraham, R.; Wallasch, C.; Ullrich, A. EGF receptor transactivation by Gprotein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature, 1999, 402(6764), 884-888. -
  77. [124][124] Pyne, N.J.; Waters, C.M.; Long, J.S.; Moughal, N.A.; Tigyi, G.; Pyne, S. Receptor tyrosine kinase-G-protein coupled receptor complex signaling in mammalian cells. Adv. Enzyme Regul., 2007, 47,271-280. -
  78. [125][125] Werry, T.D.; Sexton, P.M.; Christopoulos, A. "Ins and outs" of seven-transmembrane receptor signalling to ERK. Trends Endocrinol. Metab., 2005, 16(1), 26-33. -
  79. [127][127] Drube, S.; Stirnweiss, J.; Valkova, C.; Liebmann, C. Ligandindependent and EGF receptor-supported transactivation: lessons from beta2-adrenergic receptor signalling. Cell Signal., 2006, 18(10), 1633-1646. -
  80. [126][126] Wetzker, R.; Bohmer, F.D. Transactivation joins multiple tracks to the ERK/MAPK cascade. Nat. Rev. Mol. Cell Biol., 2003, 4(8), 651-657. -
  81. [128][128] Biscardi, J.S.; Ishizawar, R.C.; Silva, C.M.; Parsons, S.J. Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer. Breast Cancer Res., 2000, 2(3), 203-210. -
  82. [129][129] Lee, F.S.; Rajagopal, R.; Kim, A.H.; Chang, P.C.; Chao, M.V. Activation of Trk neurotrophin receptor signaling by pituitary adenylate cyclase-activating polypeptides. J. Biol. Chem., 2002, 277(11), 9096-9102. -
  83. [130][130] Lin, X.; Li, X.; Jiang, M.; Chen, L.; Xu, C.; Zhang, W.; Zhao, H.; Sun, B.; Xu, X.; Nan, F.; Liu, J. An activity-based probe reveals dynamic protein-protein interactions mediating IGF-1R transactivation by the GABA(B) receptor. Biochem. J., 2012, 443(3), 627-634. -
  84. [131][131] Flajolet, M.; Wang, Z.; Futter, M.; Shen, W.; Nuangchamnong, N.; Bendor, J.; Wallach, I.; Nairn, A.C.; Surmeier, D.J.; Greengard, P. FGF acts as a co-transmitter through adenosine A(2A) receptor to regulate synaptic plasticity. Nat. Neurosci., 2008, 11(12), 14021409. -
  85. [133][133] Huang, Y.Z.; Pan, E.; Xiong, Z.Q.; McNamara, J.O. Zinc-mediated transactivation of TrkB potentiates the hippocampal mossy fiberCA3 pyramid synapse. Neuron, 2008, 57(4), 546-558. -
  86. [132][132] Huang, Y.Z.; McNamara, J.O. Neuroprotective effects of reactive oy te a-enn t te tor TrkB. J. Neurosci., 2012, 32(44), 15521-15532. -
  87. [134][134] Burch, M.L.; Osman, N.; Getachew, R.; Al-aryahi, S.; Poronnik, P.; Zheng, W.; Hill, M.A.; Little, P.J. G protein coupled receptor transactivation: extending the paradigm to include serine/threonine kinase receptors. Int. J. Biochem. Cell Biol., 2012, 44(5), 722-727. -
  88. [136][136] Jorissen, R.N.; Walker, F.; Pouliot, N.; Garrett, T.P.; Ward, C.W.; Burgess, A.W. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp. Cell Res., 2003, 284(1), 31-53. -
  89. [135][135] Little, P.J.; Burch, M.L.; Getachew, R.; Al-aryahi, S.; Osman, N. Endothelin-1 stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by endothelin receptor transactivation of the transforming growth factor-[beta] type I receptor. J. Cardiovasc. Pharmacol., 2010, 56(4), 360-368. -
  90. [137][137] Asakura, M.; Kitakaze, M.; Takashima, S.; Liao, Y.; Ishikura, F.; Yoshinaka, T.; Ohmoto, H.; Node, K.; Yoshino, K.; Ishiguro, H.; Asanuma, H.; Sanada, S.; Matsumura, Y.; Takeda, H.; Beppu, S.; Tada, M.; Hori, M.; Higashiyama, S. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat. Med., 2002, 8(1), 35-40. -
  91. [139][139] Yan, Y.; Shirakabe, K.; Werb, Z. The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors. J. Cell Biol., 2002, 158(2), 221-226. -
  92. [138][138] Cheng, C.Y.; Tseng, H.C.; Yang, C.M. Bradykinin-mediated cell proliferation depends on transactivation of EGF receptor in corneal fibroblasts. J. Cell Physiol, 2012, 227(4), 1367-1381. -
  93. [140][140] Moody, T.W.; Sancho, V.; di, F.A.; Nuche-Berenguer, B.; Mantey, S.; Jensen, R.T. Bombesin receptor subtype-3 agonists stimulate the growth of lung cancer cells and increase EGF receptor tyrosine phosphorylation. Peptides, 2011, 32(8), 1677-1684. -
  94. [141][141] McElroy, S.J.; Hobbs, S.; Kallen, M.; Tejera, N.; Rosen, M.J.; Grishin, A.; Matta, P.; Schneider, C.; Upperman, J.; Ford, H.; Polk, D.B.; Weitkamp, J.H. Transactivation of EGFR by LPS induces COX-2 expression in enterocytes. PLoS One, 2012, 7(5), e38373. -
  95. [142][142] Hsu, D.; Fukata, M.; Hernandez, Y.G.; Sotolongo, J.P.; Goo, T.; Maki, J.; Hayes, L.A.; Ungaro, R.C.; Chen, A.; Breglio, K.J.; Xu, R.; Abreu, M.T. Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injury. Lab. Invest., 2010, 90(9), 1295-1305. -
  96. [144][144] Cussac, D.; Schaak, S.; Denis, C.; Paris, H. alpha 2B-adrenergic receptor activates MAPK via a pathway involving arachidonic acid metabolism, matrix metalloproteinases, and epidermal growth factor receptor transactivation. J. Biol. Chem., 2002, 277(22), 19882-19888. -
  97. [143][143] Prevot, V.; Cornea, A.; Mungenast, A.; Smiley, G.; Ojeda, S.R. Activation of erbB-1 signaling in tanycytes of the median eminence stimulates transforming growth factor beta1 release via prostaglandin E2 production and induces cell plasticity. J. Neurosci., 2003, 23(33), 10622-10632. -
  98. [145][145] Xie, K.Q.; Zhang, L.M.; Cao, Y.; Zhu, J.; Feng, L.Y. Adenosine A(1) receptor-mediated transactivation of the EGF receptor produces a neuroprotective effect on cortical neurons in vitro. Acta Pharmacol. Sin., 2009, 30(7), 889-898. -
  99. [146][146] Milenkovic, I.; Weick, M.; Wiedemann, P.; Reichenbach, A.; Bringmann, A. P2Y receptor-mediated stimulation of Muller glial cell DNA synthesis: dependence on EGF and PDGF receptor transactivation. Invest Ophthalmol. Vis. Sci., 2003, 44(3), 12111220. -
  100. [148][148] Peavy, R.D.; Chang, M.S.; Sanders-Bush, E.; Conn, P.J. Metabotropic glutamate receptor 5-induced phosphorylation of extracellular signal-regulated kinase in astrocytes depends on transactivation of the epidermal growth factor receptor. J. Neurosci., 2001, 21(24), 9619-9628. -
  101. [147][147] Li, B.; Zhang, S.; Zhang, H.; Nu, W.; Cai, L.; Hertz, L.; Peng, L. Fluoxetine-mediated 5-HT2B receptor stimulation in astrocytes causes EGF receptor transactivation and ERK phosphorylation. Psychopharmacology (Berl), 2008, 201(3), 443-458. -
  102. [149][149] Heldin, C.H.; Westermark, B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev., 1999, 79(4), 12831316. -
  103. [150][150] Liu, Y.; Li, M.; Warburton, R.R.; Hill, N.S.; Fanburg, B.L. The 5HT transporter transactivates the PDGFbeta receptor in pulmonary artery smooth muscle cells. FASEB J., 2007, 21(11), 2725-2734. -
  104. [151][151] Nebigil, C.G.; Launay, J.M.; Hickel, P.; Tournois, C.; Maroteaux, L. 5-hydroxytryptamine 2B receptor regulates cell-cycle progression: cross-talk with tyrosine kinase pathways. Proc. Natl. Acad. Sci. U. S. A, 2000, 97(6), 2591-2596. -
  105. [152][152] Kruk, J.S.; Vasefi, M.S.; Liu, H.; Heikkila, J.J.; Beazely, M.A. 5HT(1A) receptors transactivate the platelet-derived growth factor receptor type beta in neuronal cells. Cell Signal., 2013, 25(1), 133143. -
  106. [153][153] Oak, J.N.; Lavine, N.; Van Tol, H.H. Dopamine D(4) and D(2L) Receptor Stimulation of the Mitogen-Activated Protein Kinase Pathway Is Dependent on trans-Activation of the Platelet-Derived Growth Factor Receptor. Mol. Pharmacol., 2001, 60(1), 92-103. -
  107. [154][154] Kotecha, S.A.; Oak, J.N.; Jackson, M.F.; Perez, Y.; Orser, B.A.; Van Tol, H.H.; MacDonald, J.F. A D2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission. Neuron, 2002, 35(6), 1111-1122. -
  108. [156][156] Wang, C.; Wu, L.L.; Liu, J.; Zhang, Z.G.; Fan, D.; Li, L. Crosstalk between angiotensin II and platelet derived growth factor-BB mediated signal pathways in cardiomyocytes. Chin Med. J. (Engl. ), 2008, 121(3), 236-240. -
  109. [155][155] Heeneman, S.; Haendeler, J.; Saito, Y.; Ishida, M.; Berk, B.C. Angiotensin II induces transactivation of two different populations of the platelet-derived growth factor beta receptor. Key role for the p66 adaptor protein Shc. J. Biol. Chem., 2000, 275(21), 1592615932. -
  110. [157][157] Tanimoto, T.; Lungu, A.O.; Berk, B.C. Sphingosine 1-phosphate transactivates the platelet-derived growth factor beta receptor and epidermal growth factor receptor in vascular smooth muscle cells. Circ. Res., 2004, 94(8), 1050-1058. -
  111. [160][160] McMahon, B.; Mitchell, D.; Shattock, R.; Martin, F.; Brady, H.R.; Godson, C. Lipoxin, leukotriene, and PDGF receptors cross-talk to regulate mesangial cell proliferation. FASEB J., 2002, 16(13), 1817-1819. -
  112. [159][159] Wang, L.; Cummings, R.; Zhao, Y.; Kazlauskas, A.; Sham, J.K.; Morris, A.; Georas, S.; Brindley, D.N.; Natarajan, V. Involvement of phospholipase D2 in lysophosphatidate-induced transactivation of platelet-derived growth factor receptor-beta in human bronchial epithelial cells. J. Biol. Chem., 2003, 278(41), 39931-39940. -
  113. [161][161] Cheng, H.L.; Steinway, M.; Delaney, C.L.; Franke, T.F.; Feldman, E.L. IGF-I promotes Schwann cell motility and survival via activation of Akt. Mol. Cell Endocrinol., 2000, 170(1-2), 211-215. -
  114. [163][163] Delcourt, N.; Thouvenot, E.; Chanrion, B.; Galeotti, N.; Jouin, P.; Bockaert, J.; Marin, P. PACAP type I receptor transactivation is essential for IGF-1 receptor signalling and antiapoptotic activity in neurons. EMBO J., 2007, 26(6), 1542-1551. -
  115. [162][162] Carro, E.; Trejo, J.L.; Nunez, A.; Torres-Aleman, I. Brain repair and neuroprotection by serum insulin-like growth factor I. Mol. Neurobiol., 2003, 27(2), 153-162. -
  116. [164][164] Tu, H.; Xu, C.; Zhang, W.; Liu, Q.; Rondard, P.; Pin, J.P.; Liu, J. GABAB receptor activation protects neurons from apoptosis via IGF-1 receptor transactivation. J. Neurosci., 2010, 30(2), 749-759. -
  117. [166][166] Arevalo, J.C.; Wu, S.H. Neurotrophin signaling: many exciting surprises! Cell Mol. Life Sci., 2006, 63(13), 1523-1537. -
  118. [165][165] Skaper, S.D. The neurotrophin family of neurotrophic factors: an overview. Methods Mol. Biol., 2012, 846, 1-12. -
  119. [167][167] Rantamaki, T.; Vesa, L.; Antila, H.; Di, L.A.; Tammela, P.; Schmitt, A.; Lesch, K.P.; Rios, M.; Castren, E. Antidepressant drugs transactivate TrkB neurotrophin receptors in the adult rodent brain independently of BDNF and monoamine transporter blockade. PLoS One, 2011, 6(6), e20567. -
  120. [169][169] Rantamaki, T.; Castren, E. Targeting TrkB neurotrophin receptor to treat depression. Expert. Opin. Ther. Targets., 2008, 12(6), 705715. -
  121. [168][168] Rantamaki, T.; Hendolin, P.; Kankaanpaa, A.; Mijatovic, J.; Piepponen, P.; Domenici, E.; Chao, M.V.; Mannisto, P.T.; Castren, E. Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain. Neuropsychopharmacology, 2007, 32(10), 2152-2162. -
  122. [170][170] Sairanen, M.; Lucas, G.; Ernfors, P.; Castren, M.; Castren, E. Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J. Neurosci., 2005, 25(5), 1089-1094. -
  123. [172][172] Lee, F.S.; Chao, M.V. Activation of Trk neurotrophin receptors in the absence of neurotrophins. Proc. Natl. Acad. Sci. U. S. A, 2001, 98(6), 3555-3560. -
  124. [171][171] Saarelainen, T.; Hendolin, P.; Lucas, G.; Koponen, E.; Sairanen, M.; MacDonald, E.; Agerman, K.; Haapasalo, A.; Nawa, H.; Aloyz, R.; Ernfors, P.; Castren, E. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J. Neurosci., 2003, 23(1), 349-357. -
  125. [173][173] Rajagopal, R.; Chao, M.V. A role for Fyn in Trk receptor transactivation by G-protein-coupled receptor signaling. Mol. Cell Neurosci., 2006, 33(1), 36-46. -
  126. [175][175] Wiese, S.; Jablonka, S.; Holtmann, B.; Orel, N.; Rajagopal, R.; Chao, M.V.; Sendtner, M. Adenosine receptor A2A-R contributes to motoneuron survival by transactivating the tyrosine kinase receptor TrkB. Proc. Natl. Acad. Sci. U. S. A, 2007, 104(43), 17210-17215. -
  127. [174][174] Shi, G.X.; Jin, L.; Andres, D.A. Src-dependent TrkA transactivation is required for pituitary adenylate cyclase-activating polypeptide 38-mediated Rit activation and neuronal differentiation. Mol. Biol. Cell, 2010, 21(9), 1597-1608. -
  128. [176][176] Swift, J.L.; Godin, A.G.; Dore, K.; Freland, L.; Bouchard, N.; Nimmo, C.; Sergeev, M.; De, K.Y.; Wiseman, P.W.; Beaulieu, J.M. Quantification of receptor tyrosine kinase transactivation through direct dimerization and surface density measurements in single cells. Proc. Natl. Acad. Sci. U. S. A, 2011, 108(17), 7016-7021. -
  129. [177][177] Beaulieu, J.M.; Gainetdinov, R.R. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol. Rev., 2011, 63(1), 182-217. -
  130. [179][179] Vaccarino, F.M.; Schwartz, M.L.; Raballo, R.; Rhee, J.; Lyn-Cook, R. Fibroblast growth factor signaling regulates growth and morphogenesis at multiple steps during brain development. Curr. Top. Dev. Biol., 1999, 46, 179-200. -
  131. [178][178] Vaccarino, F.M.; Schwartz, M.L.; Raballo, R.; Nilsen, J.; Rhee, J.; Zhou, M.; Doetschman, T.; Coffin, J.D.; Wyland, J.J.; Hung, Y.T. Changes in cerebral cortex size are governed by fibroblast growth factor during embryogenesis. Nat. Neurosci., 1999, 2(3), 246-253. -
  132. [180][180] Molteni, R.; Fumagalli, F.; Magnaghi, V.; Roceri, M.; Gennarelli, M.; Racagni, G.; Melcangi, R.C.; Riva, M.A. Modulation of fibroblast growth factor-2 by stress and corticosteroids: from developmental events to adult brain plasticity. Brain Res. Brain Res. Rev., 2001, 37(1-3), 249-258. -
  133. [182][182] Vicario-Abejon, C.; Johe, K.K.; Hazel, T.G.; Collazo, D.; McKay, R.D. Functions of basic fibroblast growth factor and neurotrophins in the differentiation of hippocampal neurons. Neuron, 1995, 15(1), 105-114. -
  134. [181][181] Grothe, C.; Wewetzer, K. Fibroblast growth factor and its implications for developing and regenerating neurons. Int. J. Dev. Biol., 1996, 40(1), 403-410. -
  135. [183][183] Wagner, J.P.; Black, I.B.; DiCicco-Bloom, E. Stimulation of neonatal and adult brain neurogenesis by subcutaneous injection of basic fibroblast growth factor. J. Neurosci., 1999, 19(14), 60066016. -
  136. [185][185] Belcheva, M.M.; Haas, P.D.; Tan, Y.; Heaton, V.M.; Coscia, C.J. The fibroblast growth factor receptor is at the site of convergence between mu-opioid receptor and growth factor signaling pathways in rat C6 glioma cells. J. Pharmacol. Exp. Ther., 2002, 303(3), 909-918. -
  137. [184][184] Gomez-Pinilla, F.; van der Wal, E.A.; Cotman, C.W. Possible coordinated gene expressions for FGF receptor, FGF-5, and FGF-2 following seizures. Exp. Neurol., 1995, 133(2), 164-174. -
  138. [186][186] Tsuchioka, M.; Takebayashi, M.; Hisaoka, K.; Maeda, N.; Nakata, Y. Serotonin (5-HT) induces glial cell line-derived neurotrophic factor (GDNF) mRNA expression via the transactivation of fibroblast growth factor receptor 2 (FGFR2) in rat C6 glioma cells. J. Neurochem., 2008, 106(1), 244-257. -
  139. [187][187] Asimaki, O.; Leondaritis, G.; Lois, G.; Sakellaridis, N.; Mangoura, D. Cannabinoid 1 receptor-dependent transactivation of fibroblast growth factor receptor 1 emanates from lipid rafts and amplifies extracellular signal-regulated kinase 1/2 activation in embryonic cortical neurons. J. Neurochem., 2011, 116(5), 866-873. -
  140. [189][189] Keely, S.J.; Uribe, J.M.; Barrett, K.E. Carbachol stimulates transactivation of epidermal growth factor receptor and mitogenactivated protein kinase in T84 cells. Implications for carbacholstimulated chloride secretion. J. Biol. Chem., 1998, 273(42), 27111-27117. -
  141. [188][188] Cheng, K.; Zimniak, P.; Raufman, J.P. Transactivation of the epidermal growth factor receptor mediates cholinergic agonistinduced proliferation of H508 human colon cancer cells. Cancer Res., 2003, 63(20), 6744-6750. -
  142. [190][190] Keely, S.J.; Calandrella, S.O.; Barrett, K.E. Carbachol-stimulated transactivation of epidermal growth factor receptor and mitogenaattt i n id tlar ca(2+), PYK-2, and p60(src). J. Biol. Chem., 2000, 275(17), 1261912625. -
  143. [192][192] Park, Y.S.; Cho, N.J. EGFR and PKC are involved in the activation of ERK1/2 and p90 RSK and the subsequent proliferation of SNU407 colon cancer cells by muscarinic acetylcholine receptors. Mol. Cell Biochem., 2012, 370(1-2), 191-198. -
  144. [191][191] McCole, D.F.; Keely, S.J.; Coffey, R.J.; Barrett, K.E. Transactivation of the epidermal growth factor receptor in colonic epithelial cells by carbachol requires extracellular release of transforming growth factor-alpha. J. Biol. Chem., 2002, 277(45), 42603-42612. -
  145. [193][193] Lin, A.L.; Zhu, B.; Zhang, W.; Dang, H.; Zhang, B.X.; Katz, M.S.; Yeh, C.K. Distinct pathways of ERK activation by the muscarinic agonists pilocarpine and carbachol in a human salivary cell line. Am. J. Physiol Cell Physiol, 2008, 294(6), C1454-C1464. -
  146. [194][194] Krieg, T.; Cui, L.; Qin, Q.; Cohen, M.V.; Downey, J.M. Mitochondrial ROS generation following acetylcholine-induced EGF receptor transactivation requires metalloproteinase cleavage of proHB-EGF. J. Mol. Cell Cardiol., 2004, 36(3), 435-443. -
  147. [195][195] Paulmichl, M.; Nasmith, P.; Hellmiss, R.; Reed, K.; Boyle, W.A.; Nerbonne, J.M.; Peralta, E.G.; Clapham, D.E. Cloning and expression of a rat cardiac delayed rectifier potassium channel. Proc. Natl. Acad. Sci. U. S. A, 1991, 88(17), 7892-7895. -
  148. [197][197] Stirnweiss, J.; Valkova, C.; Ziesche, E.; Drube, S.; Liebmann, C. Muscarinic M2 receptors mediate transactivation of EGF receptor through Fyn kinase and without matrix metalloproteases. Cell Signal., 2006, 18(8), 1338-1349. -
  149. [196][196] Tsai, W.; Morielli, A.D.; Peralta, E.G. The m1 muscarinic acetylcholine receptor transactivates the EGF receptor to modulate ion channel activity. EMBO J., 1997, 16(15), 4597-4605. -
  150. [198][198] Edelstein, J.; Hao, T.; Cao, Q.; Morales, L.; Rockwell, P. Crosstalk between VEGFR2 and muscarinic receptors regulates the mTOR pathway in serum starved SK-N-SH human neuroblastoma cells. Cell Signal., 2011, 23(1), 239-248. -
  151. [200][200] Greenwood, J.M.; Dragunow, M. M3 muscarinic receptors promote cell survival through activation of the extracellular regulated kinase (ERK1/2) pathway. Eur. J. Pharmacol., 2010, 640(1-3), 38-45. -
  152. [199][199] Gomes, E.; Papa, L.; Hao, T.; Rockwell, P. The VEGFR2 and PKA pathways converge at MEK/ERK1/2 to promote survival in serum deprived neuronal cells. Mol. Cell Biochem., 2007, 305(1-2), 179190. -
  153. [201][201] Zhou, W.; Zhu, X.; Zhu, L.; Cui, Y.Y.; Wang, H.; Qi, H.; Ren, Q.S.; Chen, H.Z. Neuroprotection of muscarinic receptor agonist pilocarpine against glutamate-induced apoptosis in retinal neurons. Cell Mol.Neurobiol., 2008, 28(2), 263-275. -
  154. [203][203] Autio, H.; Matlik, K.; Rantamaki, T.; Lindemann, L.; Hoener, M.C.; Chao, M.; Arumae, U.; Castren, E. Acetylcholinesterase inhibitors rapidly activate Trk neurotrophin receptors in the mouse hippocampus. Neuropharmacology, 2011, 61(8), 1291-1296. -
  155. [202][202] Gomes, E.; Rockwell, P. p38 MAPK as a negative regulator of VEGF/VEGFR2 signaling pathway in serum deprived human SKN-SH neuroblastoma cells. Neurosci. Lett., 2008, 431(2), 95-100. -
  156. [204][204] Stefano, L.; Rossler, O.G.; Griesemer, D.; Hoth, M.; Thiel, G. P2X(7) receptor stimulation upregulates Egr-1 biosynthesis involving a cytosolic Ca(2+) rise, transactivation of the EGF receptor and phosphorylation of ERK and Elk-1. J. Cell Physiol, 2007, 213(1), 36-44. -
  157. [206][206] Gage, F.H.; Kempermann, G.; Palmer, T.D.; Peterson, D.A.; Ray, J. Multipotent progenitor cells in the adult dentate gyrus. J. Neurobiol., 1998, 36(2), 249-266. -
  158. [205][205] Dziedzic, B.; Prevot, V.; Lomniczi, A.; Jung, H.; Cornea, A.; Ojeda, S.R. Neuron-to-glia signaling mediated by excitatory amino acid receptors regulates ErbB receptor function in astroglial cells of the neuroendocrine brain. J. Neurosci., 2003, 23(3), 915-926. -
  159. [207][207] Palmer, T.D.; Markakis, E.A.; Willhoite, A.R.; Safar, F.; Gage, F.H. Fibroblast growth factor-2 activates a latent neurogenic program in neural stem cells from diverse regions of the adult CNS. J. Neurosci., 1999, 19(19),8487-8497. -
  160. [208][208] Vescovi, A.L.; Reynolds, B.A.; Fraser, D.D.; Weiss, S. bFGF regulates the proliferative fate of unipotent (neuronal) and bipotent (neuronal/astroglial) EGF-generated CNS progenitor cells. Neuron, 1993, 11(5), 951-966. -
  161. [209][209] Gritti, A.; Frolichsthal-Schoeller, P.; Galli, R.; Parati, E.A.; Cova, L.; Pagano, S.F.; Bjornson, C.R.; Vescovi, A.L. Epidermal and fibroblast growth factors behave as mitogenic regulators for a single multipotent stem cell-like population from the subventricular region of the adult mouse forebrain. J. Neurosci., 1999, 19(9), 3287-3297. -
  162. [210][210] Jin, K.; Sun, Y.; Xie, L.; Batteur, S.; Mao, X.O.; Smelick, C.; Logvinova, A.; Greenberg, D.A. Neurogenesis and aging: FGF-2 and HB-EGF restore neurogenesis in hippocampus and subventricular zone of aged mice. Aging Cell, 2003, 2(3), 175-183. -
  163. [212][212] Raballo, R.; Rhee, J.; Lyn-Cook, R.; Leckman, J.F.; Schwartz, M.L.; Vaccarino, F.M. Basic fibroblast growth factor (Fgf2) is necessary for cell proliferation and neurogenesis in the developing cerebral cortex. J. Neurosci., 2000, 20(13), 5012-5023. -
  164. [211][211] Tao, Y.; Black, I.B.; DiCicco-Bloom, E. In vivo neurogenesis is inhibited by neutralizing antibodies to basic fibroblast growth factor. J. Neurobiol., 1997, 33(3), 289-296. -
  165. [213][213] Lie, D.C.; Dziewczapolski, G.; Willhoite, A.R.; Kaspar, B.K.; Shults, C.W.; Gage, F.H. The adult substantia nigra contains progenitor cells with neurogenic potential. J. Neurosci., 2002, 22(15), 6639-6649. -
  166. [214][214] Palmer, T.D.; Ray, J.; Gage, F.H. FGF-2-responsive neuronal progenitors reside in proliferative and quiescent regions of the adult rodent brain. Mol. Cell Neurosci., 1995, 6(5), 474-486. -
  167. [216][216] Walicke, P.; Cowan, W.M.; Ueno, N.; Baird, A.; Guillemin, R. Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhances neurite extension. Proc. Natl. Acad. Sci. U. S. A, 1986, 83(9), 3012-3016. -
  168. [215][215] Rai, K.S.; Hattiangady, B.; Shetty, A.K. Enhanced production and dendritic growth of new dentate granule cells in the middle-aged hippocampus following intracerebroventricular FGF-2 infusions. Eur. J. Neurosci., 2007, 26(7), 1765-1779. -
  169. [217][217] Aoyagi, A.; Nishikawa, K.; Saito, H.; Abe, K. Characterization of basic fibroblast growth factor-mediated acceleration of axonal branching in cultured rat hippocampal neurons. Brain Res., 1994, 661(1-2), 117-126. -
  170. [218][218] Ramirez, J.J.; Finklestein, S.P.; Keller, J.; Abrams, W.; George, M.N.; Parakh, T. Basic fibroblast growth factor enhances axonal sprouting after cortical injury in rats. Neuroreport, 1999, 10(6), 1201-1204. -
  171. [219][219] Graham, B.M.; Richardson, R. Acute systemic fibroblast growth factor-2 enhances long-term extinction of fear and reduces reinstatement in rats. Neuropsychopharmacology, 2009, 34(7), 1875-1882. -
  172. [221][221] Turner, C.A.; Akil, H.; Watson, S.J.; Evans, S.J. The fibroblast growth factor system and mood disorders. Biol. Psychiatry, 2006, 59(12), 1128-1135. -
  173. [220][220] Johnson, D.E.; Williams, L.T. Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res., 1993, 60, 141. -
  174. [222][222] Stauber, D.J.; DiGabriele, A.D.; Hendrickson, W.A. Structural interactions of fibroblast growth factor receptor with its ligands. Proc. Natl. Acad. Sci. U. S. A, 2000, 97(1), 49-54. -
  175. [224][224] Mohammadi, M.; Dikic, I.; Sorokin, A.; Burgess, W.H.; Jaye, M.; Schlessinger, J. Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction. Mol. Cell Biol., 1996, 16(3), 977-989. -
  176. [223][223] Ibrahimi, O.A.; Zhang, F.; Hrstka, S.C.; Mohammadi, M.; Linhardt, R.J. Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly. Biochemistry, 2004, 43(16), 4724-4730. -
  177. [225][225] Wiedlocha, A.; Sorensen, V. Signaling, internalization, and intracellular activity of fibroblast growth factor. Curr. Top. Microbiol. Immunol., 2004, 286, 45-79. -
  178. [227][227] Asai, T.; Wanaka, A.; Kato, H.; Masana, Y.; Seo, M.; Tohyama, M. Differential expression of two members of FGF receptor gene family, FGFR-1 and FGFR-2 mRNA, in the adult rat central nervous system. Brain Res. Mol. Brain Res., 1993, 17(1-2), 174178. -
  179. [226][226] Belluardo, N.; Wu, G.; Mudo, G.; Hansson, A.C.; Pettersson, R.; Fuxe, K. Comparative localization of fibroblast growth factor receptor-1, -2, and -3 mRNAs in the rat brain: in situ hybridization analysis. J. Comp Neurol., 1997, 379(2), 226-246. -
  180. [228][228] Yazaki, N.; Hosoi, Y.; Kawabata, K.; Miyake, A.; Minami, M.; Satoh, M.; Ohta, M.; Kawasaki, T.; Itoh, N. Differential expression patterns of mRNAs for members of the fibroblast growth factor receptor family, FGFR-1-FGFR-4, in rat brain. J. Neurosci. Res., 1994, 37(4), 445-452. -
  181. [229][229] Takami, K.; Matsuo, A.; Terai, K.; Walker, D.G.; McGeer, E.G.; McGeer, P.L. Fibroblast growth factor receptor-1 expression in the cortex and hippocampus in Alzheimer's disease. Brain Res., 1998, 802(1-2), 89-97. -
  182. [230][230] Miyake, A.; Hattori, Y.; Ohta, M.; Itoh, N. Rat oligodendrocytes and astrocytes preferentially express fibroblast growth factor receptor-2 and -3 mRNAs. J. Neurosci. Res., 1996, 45(5), 534-541. -
  183. [231][231] Fuhrmann, V.; Kinkl, N.; Leveillard, T.; Sahel, J.; Hicks, D. Fibroblast growth factor receptor 4 (FGFR4) is expressed in adult rat and human retinal photoreceptors and neurons. J. Mol. Neurosci., 1999, 13(1-2), 187-197. -
  184. [233][233] Belluardo, N.; Mudo, G.; Caniglia, G.; Cheng, Q.; Blum, M.; Fuxe, K. The nicotinic acetylcholine receptor agonist ABT-594 increases FGF-2 expression in various rat brain regions. Neuroreport, 1999, 10(18), 3909-3913. -
  185. [232][232] Belluardo, N.; Blum, M.; Mudo, G.; Andbjer, B.; Fuxe, K. Acute intermittent nicotine treatment produces regional increases of basic fibroblast growth factor messenger RNA and protein in the tel- and diencephalon of the rat. Neuroscience, 1998, 83(3), 723-740. -
  186. [234][234] Belluardo, N.; Mudo, G.; Blum, M.; Cheng, Q.; Caniglia, G.; Dell'Albani, P.; Fuxe, K. The nicotinic acetylcholine receptor agonist (+/-)-epibatidine increases FGF-2 mRNA and protein levels in the rat brain. Brain Res. Mol. Brain Res., 1999, 74(1-2), 98-110. -
  187. [236][236] Son, J.H.; Winzer-Serhan, U.H. Chronic neonatal nicotine exposure increases mRNA expression of neurotrophic factors in the postnatal rat hippocampus. Brain Res., 2009, 1278, 1-14. -
  188. [235][235] Maggio, R.; Riva, M.; Vaglini, F.; Fornai, F.; Racagni, G.; Corsini, G.U. Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism. J. Neural Transm., 1997, 104(10), 1113-1123. -
  189. [237][237] Belluardo, N.; Mudo', G.; Bonomo, A.; Di, L., V; Frinchi, M.; Fuxe, K. Nicotine-induced fibroblast growth factor-2 restores the age-related decline of precursor cell proliferation in the subventricular zone of rat brain. Brain Res., 2008, 1193, 12-24. -
  190. [238][238] Stachowiak, M.K.; Moffett, J.; Joy, A.; Puchacz, E.; Florkiewicz, R.; Stachowiak, E.K. Regulation of bFGF gene expression and subcellular distribution of bFGF protein in adrenal medullary cells. J. Cell Biol., 1994, 127(1), 203-223. -
  191. [239][239] Moffett, J.; Kratz, E.; Stachowiak, M.K. Increased tyrosine phosphorylation and novel cis-acting element mediate activation of ti ct i t ( -ct iouirt siait nic acetylcholine receptor. New mechanism for trans-synaptic regulation of cellular development and plasticity. Brain Res. Mol. Brain Res., 1998, 55(2), 293-305. -
  192. [241][241] Cucina, A.; Corvino, V.; Sapienza, P.; Borrelli, V.; Lucarelli, M.; Scarpa, S.; Strom, R.; Santoro-D'Angelo, L.; Cavallaro, A. Nicotine regulates basic fibroblastic growth factor and transforming growth factor beta1 production in endothelial cells. Biochem. Biophys. Res. Commun., 1999, 257(2), 306-312. -
  193. [240][240] Cucina, A.; Sapienza, P.; Corvino, V.; Borrelli, V.; Mariani, V.; Randone, B.; Santoro, D.L.; Cavallaro, A. Nicotine-induced smooth muscle cell proliferation is mediated through bFGF and TGF-beta 1. Surgery, 2000, 127(3), 316-322. -
  194. [242][242] Blum, M.; Wu, G.; Mudo, G.; Belluardo, N.; Andersson, K.; Agnati, L.F.; Fuxe, K. Chronic continuous infusion of (-)nicotine reduces basic fibroblast growth factor messenger RNA levels in the ventral midbrain of the intact but not of the 6-hydroxydopaminelesioned rat. Neuroscience, 1996, 70(1), 169-177. -
  195. [244][244] Barathi, V.A.; Weon, S.R.; Beuerman, R.W. Expression of muscarinic receptors in human and mouse sclera and their role in the regulation of scleral fibroblasts proliferation. Mol. Vis., 2009, 15, 1277-1293. -
  196. [243][243] Liu, F.L.; Fuxe, K.; Belluardo, N.; Leo, G.; Agnati, L.F.; Aguirre, J.A. Acute intermittent nicotine treatment produces a reduction in the total number of FGF-2 immunoreactive astroglial cells in the substantia nigra of the rat: a stereological analysis. Neurosci. Lett., 2004, 355(3), 181-184. -
  197. [245][245] Borroto-Escuela, D.O.; Romero-Fernandez, W.; Garriga, P.; Ciruela, F.; Narvaez, M.; Tarakanov, A.O.; Palkovits, M.; Agnati, L.F.; Fuxe, K. G protein-coupled receptor heterodimerization in the brain. Methods Enzymol., 2013, 521, 281-294.

Cited by

See all 21

Metadata

Authors
Liberto, V., Mudo, G., Fuxe, K., & Belluardo, N.
Affiliations
University of Palermo (IT)
Venue
Current Protein & Peptide Science
Published
2014-09-01
Volume
15
Issue
7
Pages
691-702
ISSN
1389-2037 (ISSN-L)
OpenAlex
W2091850319
Cited by
19
References
43
Citations by year
2025: 2 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 3 · 2018: 6 · 2016: 3 · 2015: 1
FWCI
0.55
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • Current Protein and Peptide Science (publishedVersion)
  • PubMed (publishedVersion)
  • Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion, other-oa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
muscarinic receptors, nicotinic acetylcholine receptors, FGFR1, FGF2, receptor transactivation, receptor tyrosine kinase signaling, G protein-coupled receptor signaling, neurotrophic factors, synaptic plasticity, cognitive function, learning and memory
MeSH terms
Animals, Brain, Humans, Neuronal Plasticity, Receptors, Cholinergic, Signal Transduction, Transcriptional Activation, Receptors, Fibroblast Growth Factor, Cholinergic Agonists, Receptor Protein-Tyrosine Kinases, Protein Interaction Maps, ErbB Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Interactions Between Cholinergic and Fibroblast Growth Factor Receptors in Brain Trophism and Plasticity. https://app.cochat.ai/papers/10.2174/1389203715666140901112245
The paper
Liberto, V., Mudo, G., Fuxe, K., & Belluardo, N. (2014). Interactions Between Cholinergic and Fibroblast Growth Factor Receptors in Brain Trophism and Plasticity. Current Protein & Peptide Science. https://doi.org/10.2174/1389203715666140901112245

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.